Actieve functies van Olivier Lemaire
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Ziphius Vaccines NV
 Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Directeur/Bestuurslid | - | - |
| Compliance Officer | 01-07-2021 | - | |
| Algemeen Adviseur | 01-07-2021 | - |
Loopbaan van Olivier Lemaire
Statistieken
Internationaal
| België | 2 |
Operationeel
| Director/Board Member | 1 |
| Compliance Officer | 1 |
| General Counsel | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Health Technology |
- Beurs
- Insiders
- Olivier Lemaire
- Ervaring
